245 related articles for article (PubMed ID: 3133308)
1. Relationship between ineffective antigen presentation by murine alveolar macrophages and their immunosuppressive function.
Mbawuike IN; Herscowitz HB
Immunology; 1988 May; 64(1):61-7. PubMed ID: 3133308
[TBL] [Abstract][Full Text] [Related]
2. The capacity of normal murine alveolar macrophages to function as antigen-presenting cells for the initiation of primary antibody-forming cell responses to sheep erythrocytes in vitro.
Kaltreider HB; Caldwell JL; Byrd PK
Am Rev Respir Dis; 1986 Jun; 133(6):1097-104. PubMed ID: 2940950
[TBL] [Abstract][Full Text] [Related]
3. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
Geppert TD; Lipsky PE
J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
[TBL] [Abstract][Full Text] [Related]
4. The role of membrane gangliosides in murine alveolar macrophage-mediated suppression of the immune response.
Mbawuike IN; Herscowitz HB
Cell Immunol; 1988 Mar; 112(1):174-86. PubMed ID: 3278813
[TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma increases alveolar macrophage Ia antigen expression despite oral administration of dexamethasone to rats.
Fuchs HJ; Czarniecki CW; Chiu HH; Sniezek M; Shellito JE
Am J Respir Cell Mol Biol; 1989 Dec; 1(6):525-32. PubMed ID: 2517778
[TBL] [Abstract][Full Text] [Related]
6. Recombinant granulocyte-macrophage colony-stimulating factor restores deficient immune responses in mice with chronic Trypanosoma cruzi infections.
Reed SG; Grabstein KH; Pihl DL; Morrissey PJ
J Immunol; 1990 Sep; 145(5):1564-70. PubMed ID: 2117033
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of class II MHC determinants on macrophages by IFN-gamma and IL-4.
Cao H; Wolff RG; Meltzer MS; Crawford RM
J Immunol; 1989 Dec; 143(11):3524-31. PubMed ID: 2479682
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augmented antigen presentation function.
Fischer HG; Frosch S; Reske K; Reske-Kunz AB
J Immunol; 1988 Dec; 141(11):3882-8. PubMed ID: 3141506
[TBL] [Abstract][Full Text] [Related]
9. Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity.
Luo Y; Yamada H; Chen X; Ryan AA; Evanoff DP; Triccas JA; O'Donnell MA
Clin Exp Immunol; 2004 Jul; 137(1):24-34. PubMed ID: 15196240
[TBL] [Abstract][Full Text] [Related]
10. In vivo and in vitro expression of macrophage membrane interleukin 1 in response to soluble and particulate stimuli.
Kurt-Jones EA; Virgin HW; Unanue ER
J Immunol; 1986 Jul; 137(1):10-4. PubMed ID: 3086442
[TBL] [Abstract][Full Text] [Related]
11. Evidence for effects of interleukin 4 (B cell stimulatory factor 1) on macrophages: enhancement of antigen presenting ability of bone marrow-derived macrophages.
Zlotnik A; Fischer M; Roehm N; Zipori D
J Immunol; 1987 Jun; 138(12):4275-9. PubMed ID: 3495588
[TBL] [Abstract][Full Text] [Related]
12. Reversal of murine alveolar macrophage-mediated suppression of plaque-forming cell response by sodium periodate.
Mbawuike IN; Luhr JE; Herscowitz HB
Cell Immunol; 1986 Apr; 99(1):300-7. PubMed ID: 3019573
[TBL] [Abstract][Full Text] [Related]
13. Antigen-specific suppression of antibody responses by T lymphocytes cytotoxic for antigen-presenting cells.
Kagaya K; Shang H; Miyakawa Y; Fukazawa Y
APMIS; 1994 Jun; 102(6):439-45. PubMed ID: 7520709
[TBL] [Abstract][Full Text] [Related]
14. Immunoregulation in the rat: cellular and molecular requirements for B cell responses to types 1, 2, and T-dependent antigens.
Eldridge JH; Kimura S; Morisaki I; Michalek SM; Hamaoka T; Hamada S; McGhee JR
J Immunol; 1985 Apr; 134(4):2236-46. PubMed ID: 2857748
[TBL] [Abstract][Full Text] [Related]
15. Modulation of macrophage Ia expression by lipopolysaccharide: stem cell requirements, accessory lymphocyte involvement, and IA-inducing factor production.
Wentworth PA; Ziegler HK
Infect Immun; 1989 Jul; 57(7):2028-36. PubMed ID: 2499542
[TBL] [Abstract][Full Text] [Related]
16. Immune complex effects on murine macrophages. II. Immune complex effects on activated macrophages cytotoxicity, membrane IL 1, and antigen presentation.
Virgin HW; Kurt-Jones EA; Wittenberg GF; Unanue ER
J Immunol; 1985 Dec; 135(6):3744-9. PubMed ID: 3877753
[TBL] [Abstract][Full Text] [Related]
17. Accessory cell activity of murine tumor-associated macrophages.
Dougherty GJ; McBride WH
J Natl Cancer Inst; 1986 Mar; 76(3):541-8. PubMed ID: 3512894
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Ia antigen expression in macrophages derived from bone marrow cells cultured in granulocyte-macrophage colony-stimulating factor or macrophage colony-stimulating factor.
Falk LA; Wahl LM; Vogel SN
J Immunol; 1988 Apr; 140(8):2652-60. PubMed ID: 3128601
[TBL] [Abstract][Full Text] [Related]
19. Role of activation in alveolar macrophage-mediated suppression of the plaque-forming cell response.
Mbawuike IN; Herscowitz HB
Infect Immun; 1988 Mar; 56(3):577-81. PubMed ID: 2830191
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte-macrophage colony-stimulating factor-cultured bone marrow-derived macrophages reveal accessory cell function and synthesis of MHC class II determinants in the absence of external stimuli.
Fischer HG; Opel B; Reske K; Reske-Kunz AB
Eur J Immunol; 1988 Aug; 18(8):1151-8. PubMed ID: 3138135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
